Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne H Cross

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
The Lancet. Neurology|September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trialsXavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.
The Journal of Clinical Investigation|January 2, 2025
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populationsClaudia Cantoni, Roman A Smirnov, Maria Firulyova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple SclerosisRoman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Ebiomedicine|January 31, 2022
Alterations of host-gut microbiome interactions in multiple sclerosisClaudia Cantoni, Qingqi Lin, Yair Dorsett, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosisLaura Ghezzi, Valeria Tosti, Lisa Shi, et al.
Neurology|September 2, 2016
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter studyAndrew J Solomon, Dennis N Bourdette, Anne H Cross, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
The Lancet. Neurology|September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trialsXavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.
The Journal of Clinical Investigation|January 2, 2025
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populationsClaudia Cantoni, Roman A Smirnov, Maria Firulyova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple SclerosisRoman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Ebiomedicine|January 31, 2022
Alterations of host-gut microbiome interactions in multiple sclerosisClaudia Cantoni, Qingqi Lin, Yair Dorsett, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosisLaura Ghezzi, Valeria Tosti, Lisa Shi, et al.
Neurology|September 2, 2016
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter studyAndrew J Solomon, Dennis N Bourdette, Anne H Cross, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Pageof 20